Methyltransferase 10 Domain-Containing Protein

Western Blot (1:1000)

Methyltransferase 10 domain-containing protein

ELISA (Assay-Dependent), Immunocytochemistry (10 µg/ml), Immunofluorescence (10 µg/ml), Western Blot (1-5 µg/ml)

DYDC1; DPY30 domain containing 1; DPY30D1; FLJ43920; bA36D19.5; BC019250 protein; OTTHUMP00000019963

Flow Cytometry (1:10-1:50), Immunohistochemistry (1:50-1:100), Western Blot (1:1000)

Protein RSM22 homolog, mitochondrial; Methyltransferase 11 domain-containing protein 1; False p73 target gene protein

Immunocytochemistry (1:10-1:50), Immunofluorescence (1:10-1:50), Immunohistochemistry (1:10-1:50), Western Blot (1:100-1:500)

SET domain-containing protein 8; PR/SET domain-containing protein 07; Lysine N-methyltransferase 5A; Histone-lysine N-methyltransferase SETD8; H4-K20-HMTase SETD8

Immunocytochemistry (Assay-Dependent), Immunofluorescence (Assay-Dependent), Immunohistochemistry (Paraffin) (1:100-1:1000), Western Blot (1:1000-1:10,000)

PR domain-containing protein 4

Immunocytochemistry (1:100), Immunofluorescence (1:100), Western Blot (1:1000)

SET domain-containing protein 8; PR/SET domain-containing protein 07; Lysine N-methyltransferase 5A; Histone-lysine N-methyltransferase SETD8; H4-K20-HMTase SETD8

Immunoprecipitation (Assay Dependent)

SET7/9; SET domain-containing protein 7; Lysine N-methyltransferase 7; Histone H3-K4 methyltransferase SETD7

Western Blot (1:100-1:500)

Tristanin; PR domain-containing protein 10

ELISA (1:32,000), Western Blot (1 µg/ml)

Tristanin; PR domain-containing protein 10

Immunoprecipitation (Assay Dependent)

Tristanin; PR domain-containing protein 10

ELISA (Assay-Dependent), Western Blot (1-5 µg/ml)

SPS1, SRML1

ELISA (1:100-1:2000), Flow Cytometry (8 µg/ml), Immunocytochemistry (1:50-1:200), Immunofluorescence (1:50-1:200), Immunohistochemistry (Frozen) (Assay-Dependent), Immunohistochemistry (Paraffin) (1:200), Western Blot (1:1000)

Positive regulatory domain I-binding factor 1; PR domain-containing protein 1; Beta-interferon gene positive regulatory domain I-binding factor; BLIMP-1; B lymphocyte-induced maturation protein 1

Flow Cytometry (1:10-1:50), Immunohistochemistry (1:10-1:50), Western Blot (1:1000)

Zinc finger MYND domain-containing protein 1; SET and MYND domain-containing protein 3

Flow Cytometry (1:10-1:50), Immunohistochemistry (Paraffin) (1:50-1:100), Western Blot (1:1000)

SET domain-containing protein 8; PR/SET domain-containing protein 07; Lysine N-methyltransferase 5A; Histone-lysine N-methyltransferase SETD8; H4-K20-HMTase SETD8

Immunohistochemistry (Paraffin) (1:100-1:1000), Western Blot (1:500-1:3000)

Wolf-Hirschhorn syndrome candidate 1 protein; Protein trithorax-5; Nuclear SET domain-containing protein 2; Multiple myeloma SET domain-containing protein

Western Blot (1:1000)

Target of methylation-induced silencing 1; PYD and CARD domain-containing protein; Caspase recruitment domain-containing protein 5

Immunohistochemistry (Paraffin) (2-4 ug/ml), Western Blot (1-3 ug/ml)

Positive regulatory domain I-binding factor 1; PR domain-containing protein 1; Beta-interferon gene positive regulatory domain I-binding factor; BLIMP-1

ChIP assay (1:10-1:500), Immunohistochemistry (Paraffin) (1:100), Western Blot (1:500-1:1000)

SET7/9; SET domain-containing protein 7; Lysine N-methyltransferase 7; Histone H3-K4 methyltransferase SETD7

Western Blot (1:500-1:3000)

SET7/9; SET domain-containing protein 7; Lysine N-methyltransferase 7; Histone H3-K4 methyltransferase SETD7

Flow Cytometry (1:10-1:50), Western Blot (1:1000)

SET and MYND domain-containing protein 1

Western Blot (0.2-1 µg/ml)

tRNA methyltransferase 10 homolog C; Renal carcinoma antigen NY-REN-49; RNA (guanine-9-)-methyltransferase domain-containing protein 1; HBV pre-S2 trans-regulated protein 2

Immunocytochemistry (1:100-1:1000), Immunofluorescence (1:100-1:1000), Western Blot (1:500-1:3000)

NOL1/NOP2/Sun domain family member 6; NOL1/NOP2/Sun and PUA domain-containing protein 1

Immunohistochemistry (Paraffin) (5-10 ug/ml), Immunoprecipitation (5 ug), Western Blot (2 ug/ml)

Flavin-containing amine oxidase domain-containing protein 2; BRAF35-HDAC complex protein BHC110

Western Blot (1:500-1:3000)

RNA (guanine-9-)-methyltransferase domain-containing protein 2

Immunohistochemistry (Paraffin) (10 µg/ml), Western Blot (1-3 µg/ml)

Flavin-containing amine oxidase domain-containing protein 2; BRAF35-HDAC complex protein BHC110

Immunocytochemistry (1:10-1:50), Immunofluorescence (1:10-1:50), Immunohistochemistry (1:50-1:100), Western Blot (1:1000)

Flavin-containing amine oxidase domain-containing protein 2; BRAF35-HDAC complex protein BHC110

Immunocytochemistry (1:10-1:50), Immunofluorescence (1:10-1:50), Immunohistochemistry (1:50-1:100), Western Blot (1:1000)

Flavin-containing amine oxidase domain-containing protein 2; BRAF35-HDAC complex protein BHC110

Immunocytochemistry (1:10-1:50), Immunofluorescence (1:10-1:50), Immunohistochemistry (1:50-1:100), Western Blot (1:1000)

PR domain-containing protein 14

Immunohistochemistry (5-10µg/ml)

WW domain-binding protein 7; Trithorax homolog 2; Myeloid/lymphoid or mixed-lineage leukemia protein 4

Immunocytochemistry (8-25 µg/ml), Immunofluorescence (8-25 µg/ml), Western Blot (2 µg/ml)

PR domain-containing protein 14